Osteoarthritis Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024

  • Published: Aug 2020
  • Pages: 120
  • SKU: IRTNTR43212

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The osteoarthritis therapeutics market size is expected to grow by USD 2.99 bn and record a CAGR of 9% during 2020-2024.

This post-pandemic global osteoarthritis therapeutics market report has assessed the shift in consumer behaviour and has identified and explored the upcoming trends and drivers that the vendors can capitalize on to support prompt business decisions. In this osteoarthritis therapeutics market analysis report, key drivers such as increasing incidence of osteoarthritis have been discussed with emerging growth regions, which will offer immense business opportunities. Our analysts have also identified challenges such as high cost of treatment, which will impede market growth. With these insights, the vendors can recreate their plan of action to obtain growth opportunities in the future.

What will the Osteoarthritis Therapeutics Market Size be in 2020?


Browse TOC and LoE with selected illustrations and example pages of Osteoarthritis Therapeutics Market

 Get Your FREE Sample Now!

Who are the Key Vendors in the Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The profiles include information on the production, competitive landscape, sustainability, and prospects of the leading companies includng:


  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Zimmer Biomet Holdings Inc.


The osteoarthritis therapeutics market is fragmented and the vendors are deploying various growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.

This osteoarthritis therapeutics market report further entails segmentations by Product (Analgesics & NSAIDs, Corticosteriods, Viscosupplements, and Others) and Geography (North America, Europe, Asia, and ROW). View our sample report to gather market insights on the segmentations.

To make the most of the opportunities, vendors should focus on fast-growing segments, while maintaining their positions in the slow-growing segments. Fetch actionable market insights on post COVID-19 impact on each product and service segments.


Which are the Key Regional Markets for Osteoarthritis Therapeutics Market?


For more insights on the market share of various regions Request for a FREE sample now!

The report offers an up-to-date analysis of the geographical composition of the market. North America had the largest market share in the osteoarthritis therapeutics market in 2020, and the region will offer several growth opportunities to market vendors during the forecast period. The availability of guidelines for disease management will significantly influence biofuels market growth in this region. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

32% of the market’s growth will originate from North America during the forecast period. The US is the key market for osteoarthritis therapeutics market in the region. This report provides estimations of the contribution of all regions to the growth of the osteoarthritis therapeutics market size.


Request for a FREE sample

What are the Key Factors Covered in this Osteoarthritis Therapeutics Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive osteoarthritis therapeutics market growth during the next five years
  • Precise estimation of the osteoarthritis therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the osteoarthritis therapeutics market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of osteoarthritis therapeutics market vendors

Need a Customized Report? Get in touch

Osteoarthritis Therapeutics Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 9%

Market growth 2020-2024

USD 2.99 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 32%

Key consumer countries

US, UK, Japan, Germany, China, and South Korea (Republic of Korea)

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The osteoarthritis therapeutics market growth will increase by $2991.85 million during 2019-2024.
The osteoarthritis therapeutics market is expected to grow at a CAGR of 8.65% during 2019-2024.
Technavio has segmented the osteoarthritis therapeutics market by product (Analgesics and NSAIDs, Corticosteriods, Viscosupplements, and Others) ,distribution channel (Offline and Online) , and geographic (North America, Europe, and Asia).
Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, Zimmer Biomet Holdings Inc. are a few of the key vendors in the osteoarthritis therapeutics market.
North America will register the highest growth rate of 37.71% among the other regions. Therefore, the osteoarthritis therapeutics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
  • US
  • UK
  • Japan
  • Germany
  • China
  • South Korea (Republic of Korea)
The key factors driving the osteoarthritis therapeutics market growth are:
  • Increasing incidence of osteoarthritis
  • Growing advances in N95 respirators
The osteoarthritis therapeutics market vendors should focus on grabbing business opportunities from the analgesics and nsaids segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>